{
    "2018-10-30": [
        [
            {
                "time": "2018-10-30",
                "original_text": "Incyte (INCY) Misses on Q3 Earnings & Revenues, Updates View",
                "features": {
                    "keywords": [
                        "Q3",
                        "Earnings",
                        "Misses",
                        "Revenues",
                        "Updates"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "Pfizer Missed Analysts’ Third-Quarter Revenue Estimates",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Missed",
                        "Analysts",
                        "Third-Quarter",
                        "Revenue",
                        "Estimates"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "Allergan (AGN) Beats on Q3 Earnings, Raises 2018 Guidance",
                "features": {
                    "keywords": [
                        "Allergan",
                        "Beats",
                        "Q3",
                        "Earnings",
                        "Raises",
                        "Guidance"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "Sanofi: Analysts’ Recommendations on October 30",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Analysts",
                        "Recommendations",
                        "October"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "Sanofi’s Q3 Estimates: Expect Revenue Growth",
                "features": {
                    "keywords": [
                        "Sanofi",
                        "Q3",
                        "Estimates",
                        "Revenue",
                        "Growth"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "Your first trade for Tuesday, Oct 30",
                "features": {
                    "keywords": [
                        "first",
                        "trade",
                        "Tuesday",
                        "Oct"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "This is Why Eli Lilly (LLY) is a Great Dividend Stock",
                "features": {
                    "keywords": [
                        "Eli",
                        "Lilly",
                        "Dividend",
                        "Stock"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "Better Buy: Celgene Corporation vs. Gilead Sciences",
                "features": {
                    "keywords": [
                        "Better",
                        "Buy",
                        "Celgene",
                        "Corporation",
                        "Gilead",
                        "Sciences"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-30",
                "original_text": "Elanco Animal Health Names Todd Young CFO - Quick Facts",
                "features": {
                    "keywords": [
                        "Elanco",
                        "Animal",
                        "Health",
                        "Names",
                        "Todd",
                        "Young",
                        "CFO"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "animal health"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}